Xtant Medical Holdings Inc (XTNT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Xtant Medical Holdings Inc stock (XTNT) is currently trading at $0.56. Xtant Medical Holdings Inc PE ratio is 58.23. Xtant Medical Holdings Inc PS ratio (Price-to-Sales) is 0.61. Analyst consensus price target for XTNT is $1.35. WallStSmart rates XTNT as Underperform.
- XTNT PE ratio analysis and historical PE chart
- XTNT PS ratio (Price-to-Sales) history and trend
- XTNT intrinsic value — DCF, Graham Number, EPV models
- XTNT stock price prediction 2025 2026 2027 2028 2029 2030
- XTNT fair value vs current price
- XTNT insider transactions and insider buying
- Is XTNT undervalued or overvalued?
- Xtant Medical Holdings Inc financial analysis — revenue, earnings, cash flow
- XTNT Piotroski F-Score and Altman Z-Score
- XTNT analyst price target and Smart Rating
Xtant Medical Holdings Inc
📊 No data available
Try selecting a different time range
XTNT Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Xtant Medical Holdings Inc (XTNT)
XTNT trades 744% above its Graham fair value of $0.07, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Xtant Medical Holdings Inc (XTNT) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, institutional own.. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Xtant Medical Holdings Inc (XTNT) Key Strengths (3)
Paying less than $1 for every $1 of annual revenue
Trading at 1.62x book value, attractively priced
57.97% held by institutions, strong professional interest
Supporting Valuation Data
Xtant Medical Holdings Inc (XTNT) Areas to Watch (6)
Very low returns on shareholder equity
Very thin margins with limited operational efficiency
Very thin margins, barely profitable
Micro-cap company with very limited liquidity and high volatility
Growth is fairly priced, not cheap, not expensive
Solid revenue growth at 19.00% per year
Supporting Valuation Data
Xtant Medical Holdings Inc (XTNT) Detailed Analysis Report
Overall Assessment
This company scores 48/100 in our Smart Analysis, earning a D+ grade. Out of 9 metrics analyzed, 3 register as strengths (avg 8.7/10) while 6 fall into concern territory (avg 3.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book, Institutional Own.. Valuation metrics including Price/Sales (0.61), Price/Book (1.62) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Some valuation metrics including PEG Ratio (1.74) suggest expensive pricing. Growth concerns include Revenue Growth at 19.00%, which may limit upside. Profitability pressure is visible in Return on Equity at 3.64%, Operating Margin at 7.64%, Profit Margin at 1.32%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 3.64% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 19.00% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
XTNT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
XTNT's Price-to-Sales ratio of 0.61x trades at a deep discount to its historical average of 3.04x (4th percentile). The current valuation is 95% below its historical high of 13.37x set in Mar 2018, and 6% above its historical low of 0.58x in Mar 2025.
WallStSmart Analysis Synopsis
Data-driven financial summary for Xtant Medical Holdings Inc (XTNT) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Xtant Medical Holdings Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 133M with 19% growth year-over-year. Profit margins are thin at 1.3%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
Generating 4M in free cash flow and 5M in operating cash flow. Earnings are translating into actual cash generation.
ROE of 3.6% suggests the company isn't efficiently converting equity into profits.
Profit margin at 1.3% is thin. While this is common for high-growth companies, margins need to expand as growth naturally decelerates.
What to Watch Next
Margin expansion: can Xtant Medical Holdings Inc push profit margins above 15% as the business scales?
Valuation compression risk at a P/E of 58.2x. Any growth miss could trigger a sharp correction.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Xtant Medical Holdings Inc.
Bottom Line
Xtant Medical Holdings Inc offers an attractive blend of growth (19% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Xtant Medical Holdings Inc(XTNT)
NYSE MKT
HEALTHCARE
MEDICAL DEVICES
USA
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company is headquartered in Belgrade, Montana.